Related Experiment Videos
Does the angiotensin II receptor antagonist losartan improve cognitive function?
Michele A Tedesco1, Gennaro Ratti, Giovanni Di Salvo
1Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Naples, Italy. Tedesco@napoli.pandora.it
Drugs & Aging
|October 23, 2002
Summary
New antihypertensive drugs like angiotensin II receptor antagonists may improve cognitive function in hypertensive patients. This benefit extends beyond blood pressure reduction, suggesting broader impacts on brain health and quality of life.
Area of Science:
- Pharmacology
- Neurology
- Cardiology
Background:
- Chronic hypertension is linked to cerebrovascular and cardiovascular diseases.
- Hypertension is associated with reduced cognitive function, particularly in untreated patients.
- Newer antihypertensive agents may offer additional patient benefits beyond blood pressure control.
Purpose of the Study:
- To investigate the cognitive effects of angiotensin II receptor antagonists in hypertensive patients.
- To explore potential mechanisms beyond blood pressure reduction for cognitive improvements.
Main Methods:
- An initial clinical trial was conducted.
- The study involved patients with hypertension, including elderly individuals.
- The effects of the angiotensin II receptor antagonist losartan were assessed.
Main Results:
- Losartan demonstrated an improvement in cognitive function in hypertensive patients.
- Cognitive benefits were observed even in elderly participants.
- The observed cognitive improvements were not solely attributable to blood pressure reduction.
Conclusions:
- Angiotensin II receptor antagonists may positively impact cognitive function in hypertensive individuals.
- The renin-angiotensin system's biological actions likely play a role in these cognitive effects.
- Improving cognitive function in hypertension offers potential economic and quality-of-life benefits, especially for the aging population.